ATNF

180 Life Sciences News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
180 Life Sciences Corporation ATNF NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.32 07:31:31
Open Price Low Price High Price Close Price Prev Close
1.32
more quote information »

Recent News

Date Time Source Heading
5/27/202206:25EDGARCurrent Report Filing (8-k)
5/23/202216:34EDGARStatement of Changes in Beneficial Ownership (4)
5/23/202216:34EDGARStatement of Changes in Beneficial Ownership (4)
5/23/202216:33EDGARStatement of Changes in Beneficial Ownership (4)
5/23/202216:32EDGARStatement of Changes in Beneficial Ownership (4)
5/23/202216:31EDGARStatement of Changes in Beneficial Ownership (4)
5/17/202217:21EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
5/17/202217:17EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
5/16/202207:03EDGARQuarterly Report (10-q)
5/09/202207:35EDGARWithdrawal of Registration Statement (ammendment) (aw)
5/09/202207:34EDGARWithdrawal of Registration Statement (ammendment) (aw)
5/09/202207:24EDGARWithdrawal of Registration Statement (ammendment) (aw)
5/02/202208:00GLOBEREPEAT - 180 Life Sciences and University of Oxford Announce..
4/29/202218:32GLOBE180 Life Sciences and University of Oxford Announce..
4/29/202206:14EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/14/202216:31EDGARCurrent Report Filing (8-k)
4/06/202216:32EDGARPost-effective Amendment to Registration Statement (pos Am)
4/06/202216:32EDGARPost-effective Amendment to Registration Statement (pos Am)
4/06/202216:32EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
4/06/202216:32EDGARPost-effective Amendment to Registration Statement (pos Am)
4/06/202216:31EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
4/06/202216:31EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
3/28/202208:31EDGARCurrent Report Filing (8-k)
2/17/202208:30GLOBE180 Life Sciences Corp. Forms Scientific Advisory Board
2/09/202215:19EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202216:31EDGARAmended Statement of Ownership (sc 13g/a)
1/31/202208:02EDGARCurrent Report Filing (8-k)
1/31/202208:00GLOBE180 Life Sciences Corp. CEO James Woody, MD, PhD Issues..
1/18/202216:32EDGARStatement of Changes in Beneficial Ownership (4)
12/28/202111:00GLOBE180 Life Sciences Corp. To Participate in the Biotech..
12/16/202117:01EDGARStatement of Changes in Beneficial Ownership (4)
12/15/202108:30SEEK180 Life Sciences inks licensing deal with University of..
12/15/202108:15GLOBE180 Life Sciences Corp. Enters into a License Agreement with..
12/14/202108:32EDGARCurrent Report Filing (8-k)
12/13/202116:22EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
12/13/202108:36EDGARStatement of Changes in Beneficial Ownership (4)
12/13/202108:32EDGARStatement of Changes in Beneficial Ownership (4)
12/10/202118:40EDGARStatement of Changes in Beneficial Ownership (4)
12/10/202118:05EDGARStatement of Changes in Beneficial Ownership (4)
12/10/202116:31EDGARStatement of Changes in Beneficial Ownership (4)
12/10/202108:24EDGARStatement of Changes in Beneficial Ownership (4)
12/10/202108:18EDGARCurrent Report Filing (8-k)
12/06/202108:16EDGARCurrent Report Filing (8-k)
12/06/202108:15GLOBE180 Life Sciences Provides Follow-Up Information on Oxford..
12/02/202113:28SEEK180 Life Sciences falls 25% following data on Humira for..
12/01/202115:11SEEK180 Life Sciences says trial for adalimumab in Dupuytren’s..
12/01/202114:45GLOBE180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal..
12/01/202114:26TRMN180 Life Sciences: Positive Data From Dupuytren’s Disease..
11/29/202106:53SEEK180 Life Sciences, Vaxart gain amid social media buzz;..
11/22/202108:30GLOBE180 Life Sciences Corp. Expands Patent Portfolio
Your Recent History
NASDAQ
ATNF
180 Life S..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220527 12:01:00